| 1. | Munshi L, Walkey A, Goligher E, et al. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir Med, 2019, 7(2): 163-172. | 
				                                                        
				                                                            
				                                                                | 2. | Aubron C, Cheng AC, Pilcher D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: A 5-year cohort study. Crit Care, 2013, 17(2): R73. | 
				                                                        
				                                                            
				                                                                | 3. | Oude Lansink-Hartgring A, de Vries AJ, Droogh JM, et al. Hemorrhagic complications during extracorporeal membrane oxygenation—The role of anticoagulation and platelets. J Crit Care, 2019, 54: 239-243. | 
				                                                        
				                                                            
				                                                                | 4. | Jiritano F, Serraino GF, Ten Cate H, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: A systematic review and meta-analysis. Intensive Care Med, 2020, 46(6): 1154-1169. | 
				                                                        
				                                                            
				                                                                | 5. | Chlebowski MM, Baltagi S, Carlson M, et al. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care, 2020, 24(1): 19. | 
				                                                        
				                                                            
				                                                                | 6. | Balle CM, Jeppesen AN, Christensen S, et al. Platelet function during extracorporeal membrane oxygenation in adult patients. Front Cardiovasc Med, 2019, 6: 114. | 
				                                                        
				                                                            
				                                                                | 7. | Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth, 2009, 13(3): 154-175. | 
				                                                        
				                                                            
				                                                                | 8. | Millar JE, Fanning JP, McDonald CI, et al. The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology. Crit Care, 2016, 20(1): 387. | 
				                                                        
				                                                            
				                                                                | 9. | Roth S, Jansen C, M'Pembele R, et al. Fibrinogen-albumin-ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO. Sci Rep, 2021, 11(1): 16648. | 
				                                                        
				                                                            
				                                                                | 10. | Acharya P, Jakobleff WA, Forest SJ, et al. Fibrinogen albumin ratio and ischemic stroke during venoarterial extracorporeal membrane oxygenation. ASAIO J, 2020, 66(3): 277-282. | 
				                                                        
				                                                            
				                                                                | 11. | Deng S, Fan Z, Xia H, et al. Fibrinogen/albumin ratio as a promising marker for predicting survival in pancreatic neuroendocrine neoplasms. Cancer Manag Res, 2021, 13: 107-115. | 
				                                                        
				                                                            
				                                                                | 12. | Chen W, Shan B, Zhou S, et al. Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma. BMC Cancer, 2022, 22(1): 92. | 
				                                                        
				                                                            
				                                                                | 13. | Descamps R, Moussa MD, Besnier E, et al. Anti-Ⅹa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): A multicenter cohort study. Crit Care, 2021, 25(1): 127. | 
				                                                        
				                                                            
				                                                                | 14. | Kumar TK, Zurakowski D, Dalton H, et al. Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg, 2010, 140(2): 330-336. | 
				                                                        
				                                                            
				                                                                | 15. | Smith A, Hardison D, Bridges B, et al. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion, 2013, 28(1): 54-60. | 
				                                                        
				                                                            
				                                                                | 16. | Fletcher-Sandersj?? A, Thelin EP, Bartek J, et al. Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: A systematic and narrative review. Front Neurol, 2018, 9: 548. | 
				                                                        
				                                                            
				                                                                | 17. | Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care, 2016, 6(1): 97. | 
				                                                        
				                                                            
				                                                                | 18. | Lotz C, Streiber N, Roewer N, et al. Therapeutic interventions and risk factors of bleeding during extracorporeal membrane oxygenation. ASAIO J, 2017, 63(5): 624-630. | 
				                                                        
				                                                            
				                                                                | 19. | Sharma NS, Wille KM, Bellot SC, et al. Modern use of extracorporeal life support in pregnancy and postpartum. ASAIO J, 2015, 61(1): 110-114. | 
				                                                        
				                                                            
				                                                                | 20. | Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal life support organization registry international report 2016. ASAIO J, 2017, 63(1): 60-67. | 
				                                                        
				                                                            
				                                                                | 21. | Luyt CE, Bréchot N, Demondion P, et al. Brain injury during venovenous extracorporeal membrane oxygenation. Intensive Care Med, 2016, 42(5): 897-907. | 
				                                                        
				                                                            
				                                                                | 22. | Grecu L. Anticoagulation for extracorporeal membrane oxygenation: Between the rock and the hard place. Crit Care Med, 2020, 48(2): 264-266. | 
				                                                        
				                                                            
				                                                                | 23. | Jiritano F, Fina D, Lorusso R, et al. Systematic review and meta-analysis of the clinical effectiveness of point-of-care testing for anticoagulation management during ECMO. J Clin Anesth, 2021, 73: 110330. | 
				                                                        
				                                                            
				                                                                | 24. | Wu MY, Lin PJ, Tseng YH, et al. Venovenous extracorporeal life support for posttraumatic respiratory distress syndrome in adults: the risk of major hemorrhages. Scand J Trauma Resusc Emerg Med, 2014, 22: 56. | 
				                                                        
				                                                            
				                                                                | 25. | Fletcher-Sandersj?? A, Bartek J, Thelin EP, et al. Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study. J Intensive Care, 2017, 5: 27. | 
				                                                        
				                                                            
				                                                                | 26. | Ellouze O, Abbad X, Constandache T, et al. Risk factors of bleeding in patients undergoing venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg, 2021, 111(2): 623-628. | 
				                                                        
				                                                            
				                                                                | 27. | Lee SH, Shin DS, Kim JR, et al. Factors associated with mortality risk in critical care patients treated with veno-arterial extracorporeal membrane oxygenation. Heart Lung, 2017, 46(3): 137-142. | 
				                                                        
				                                                            
				                                                                | 28. | Amaro E, Moore-Lotridge SN, Wessinger B, et al. Albumin and the fibrinogen-to-albumin ratio: Biomarkers for the acute phase response following total knee arthroplasty. PLoS One, 2021, 16(2): e0247070. | 
				                                                        
				                                                            
				                                                                | 29. | Zhang DP, Mao XF, Wu TT,  et al. The fibrinogen-to-albumin ratio is associated with outcomes in patients with coronary artery disease who underwent percutaneous coronary intervention. Clin Appl Thromb Hemost, 2020, 26: 1076029620933008. | 
				                                                        
				                                                            
				                                                                | 30. | Mulvihill JN, Faradji A, Oberling F, et al. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies. J Biomed Mater Res, 1990, 24(2): 155-163. | 
				                                                        
				                                                            
				                                                                | 31. | An Q, Liu W, Yang Y, et al. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage ⅠB-ⅡA cervical cancer. BMC Cancer, 2020, 20(1): 691. | 
				                                                        
				                                                            
				                                                                | 32. | Wang P, Yuan D, Zhang C, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol, 2022, 21(1): 46. |